Channing Capital Management, LLC Nuvasive Inc Transaction History

Channing Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$35.68 - $44.71 $2.55 Million - $3.2 Million	-71,535 Reduced 5.72%	1,179,211 $48.6 Million
Q3 2022 Nov 08, 2022	SELL	$42.51 - $54.02 $3.48 Million - $4.42 Million	-81,792 Reduced 6.14%	1,250,746 $54.8 Million
Q2 2022 Aug 11, 2022	BUY	$46.84 - $59.75 $7.66 Million - $9.78 Million	163,613 Added 14.0%	1,332,538 $65.5 Million
Q1 2022 May 12, 2022	BUY	$48.09 - $57.79 $5.73 Million - $6.88 Million	119,121 Added 11.35%	1,168,925 $66.3 Million
Q4 2021 Feb 11, 2022	BUY	$47.19 - $62.68 $6.21 Million - $8.24 Million	131,537 Added 14.32%	1,049,804 $55.1 Million
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $6.22 Million - $7.41 Million	109,225 Added 13.5%	918,267 $55 Million
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $9.8 Million - $11 Million	153,016 Added 23.32%	809,042 $54.8 Million
Q1 2021 May 14, 2021	BUY	$53.26 - $68.08 $3.26 Million - $4.17 Million	61,227 Added 10.29%	656,026 $43 Million
Q4 2020 Feb 11, 2021	BUY	$43.41 - $56.51 $25.8 Million - $33.6 Million	594,799 New	594,799 $33.5 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Channing Capital Management, LLC with notifications on news.